AGT and COVID-19: It is known that COVID-19 stimulates unbalanced activation of the renin-angiotensin-aldosterone system (RAAS), causing regulation of ACE2 membrane-bound receptors that promote the accumulation of angiotensin II by reducing its degradation into angiotensin 1 [7].